Cargando…

Immunoprecipitation methods impact the peptide repertoire in immunopeptidomics

INTRODUCTION: Mass spectrometry-based immunopeptidomics is the only unbiased method to identify naturally presented HLA ligands, which is an indispensable prerequisite for characterizing novel tumor antigens for immunotherapeutic approaches. In recent years, improvements based on devices and methodo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wacker, Marcel, Bauer, Jens, Wessling, Laura, Dubbelaar, Marissa, Nelde, Annika, Rammensee, Hans-Georg, Walz, Juliane S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400765/ https://www.ncbi.nlm.nih.gov/pubmed/37545538 http://dx.doi.org/10.3389/fimmu.2023.1219720

Ejemplares similares

Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia
por: Nelde, Annika, et al.
Publicado: (2021)

TOF(IMS) mass spectrometry-based immunopeptidomics refines tumor antigen identification
por: Hoenisch Gravel, Naomi, et al.
Publicado: (2023)

The Peptide Vaccine of the Future
por: Nelde, Annika, et al.
Publicado: (2021)

Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunity
por: Nelde, Annika, et al.
Publicado: (2022)

Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease Outcome
por: Marconato, Maddalena, et al.
Publicado: (2022)

Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumors
por: Marcu, Ana, et al.
Publicado: (2021)

Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?
por: Roerden, Malte, et al.
Publicado: (2019)

T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals
por: Bilich, Tatjana, et al.
Publicado: (2021)

Antigen Targets for the Development of Immunotherapies in Leukemia
por: Bauer, Jens, et al.
Publicado: (2019)

The immunopeptidomic landscape of ovarian carcinomas
por: Schuster, Heiko, et al.
Publicado: (2017)

The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
por: Bauer, Jens, et al.
Publicado: (2022)

HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation
por: Roerden, Malte, et al.
Publicado: (2020)

Upstream open reading frames regulate translation of cancer-associated transcripts and encode HLA-presented immunogenic tumor antigens
por: Nelde, Annika, et al.
Publicado: (2022)

HLA-DR Presentation of the Tumor Antigen MSLN Associates with Clinical Outcome of Ovarian Cancer Patients
por: Tegeler, Christian M., et al.
Publicado: (2022)

Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues
por: Kubiniok, Peter, et al.
Publicado: (2022)

Alterations in the HLA-B*57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated Peptides
por: Puig, Montserrat, et al.
Publicado: (2021)

Comprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the Immunopeptidome
por: Schellens, Ingrid M. M., et al.
Publicado: (2015)

The yin/yang balance of the MHC-self-immunopeptidome
por: Santambrogio, Laura, et al.
Publicado: (2022)

Are There Indeed Spliced Peptides in the Immunopeptidome?
por: Admon, Arie
Publicado: (2021)

Mass spectrometry-based identification of a B-cell maturation antigen-derived T-cell epitope for antigen-specific immunotherapy of multiple myeloma
por: Bilich, Tatjana, et al.
Publicado: (2020)

Accurate MHC Motif Deconvolution of Immunopeptidomics Data Reveals a Significant Contribution of DRB3, 4 and 5 to the Total DR Immunopeptidome
por: Kaabinejadian, Saghar, et al.
Publicado: (2022)

The Impact of Biomaterial Cell Contact on the Immunopeptidome
por: Ghosh, Michael, et al.
Publicado: (2020)

Editorial: Immunopeptidomic Approaches for the Identification of Tumor (neo)Antigens
por: Lill, Jennie R., et al.
Publicado: (2022)

The HLA class-II immunopeptidomes of AAV capsids proteins
por: Brito-Sierra, Carlos A., et al.
Publicado: (2022)

The HLA class I immunopeptidomes of AAV capsid proteins
por: Brito-Sierra, Carlos A., et al.
Publicado: (2023)

Commentary: Are There Indeed Spliced Peptides in the Immunopeptidome?
por: Mishto, Michele
Publicado: (2021)

Mining the Immunopeptidome for Antigenic Peptides in Cancer
por: León-Letelier, Ricardo A., et al.
Publicado: (2022)

Molecular Determinants Regulating the Plasticity of the MHC Class II Immunopeptidome
por: Santambrogio, Laura
Publicado: (2022)

Integrated Immunopeptidomic and Proteomic Analysis of COVID-19 lung biopsies
por: Yin, Shanye, et al.
Publicado: (2023)

Erratum: The HLA class-II immunopeptidomes of AAV capsids proteins
Publicado: (2023)

Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows
por: Partridge, Thomas, et al.
Publicado: (2018)

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
por: Heitmann, Jonas S., et al.
Publicado: (2021)

Quantification of HLA-DM-Dependent Major Histocompatibility Complex of Class II Immunopeptidomes by the Peptide Landscape Antigenic Epitope Alignment Utility
por: Álvaro-Benito, Miguel, et al.
Publicado: (2018)

Tapasin-mediated editing of the MHC I immunopeptidome is epitope specific and dependent on peptide off-rate, abundance, and level of tapasin expression
por: Boulanger, Denise S. M., et al.
Publicado: (2022)

An Integrated Genomic, Proteomic, and Immunopeptidomic Approach to Discover Treatment-Induced Neoantigens
por: Olsson, Niclas, et al.
Publicado: (2021)

The Importance of Being Presented: Target Validation by Immunopeptidomics for Epitope-Specific Immunotherapies
por: Becker, Jonas P., et al.
Publicado: (2022)

SAPrIm, a semi-automated protocol for mid-throughput immunopeptidomics
por: Lim Kam Sian, Terry C. C., et al.
Publicado: (2023)

Pro-inflammatory Cytokines Alter the Immunopeptidome Landscape by Modulation of HLA-B Expression
por: Javitt, Aaron, et al.
Publicado: (2019)

Immunopeptidomic Data Integration to Artificial Neural Networks Enhances Protein-Drug Immunogenicity Prediction
por: Barra, Carolina, et al.
Publicado: (2020)

Is the Immunopeptidome Getting Darker?: A Commentary on the Discussion around Mishto et al., 2019
por: Purcell, Anthony W.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6p3umr9h1o6lt0hued67kh6cve